Sandra Milligan - 14 May 2024 Form 3 Insider Report for Spyre Therapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Issuer symbol
SYRE
Transactions as of
14 May 2024
Net transactions value
$0
Form type
3
Filing time
16 May 2024, 16:05:36 UTC
Previous filing
06 May 2024
Next filing
06 Jun 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney